A bitter pill to swallow: Medication adherence barriers in adolescents and young adults with inflammatory bowel diseases

Greenley, Rachel Neff; Reed-Knight, Bonney; Wojtowicz, Andrea A.; Plevinsky, Jill M.; Lewis, Jeffery D.; Kahn, Stacy A.

doi:10.1080/02739615.2017.1383911

Cited by 2 publications

(2 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition to being at risk for substance use, AYAs with IBD are at risk for poorer physical and behavioral health, in part due to the unpredictable nature of the illness and the complexity of the treatment regimen (14). Notably, difficulties with self-management (eg, increased reported barriers to adherence, deficits in disease management skills) have been associated with greater disease activity, poorer self-efficacy, and poorer health-related quality of life (HRQoL) in this population as well (15)(16)(17). Therefore, IBD is a model condition in which to study relationships between substance use and physical and behavioral health outcomes.…”

Section: What Is Newmentioning

confidence: 99%

Substance Use in Adolescents and Young Adults With Inflammatory Bowel Diseases

Plevinsky

Maddux

Greenley

2019

J. pediatr. gastroenterol. nutr.

Self Cite

View full text Add to dashboard Cite

Objectives: Adolescents and young adults (AYAs) with chronic illnesses use substances at similar, if not greater, rates compared to healthy peers. The present study aimed to examine rates and patterns of tobacco use, marijuana use, and binge drinking in AYAs with inflammatory bowel diseases. We expected that substance use would be associated with poorer physical health, psychosocial functioning, and disease management. Methods: One hundred thirty-two AYAs completed a single set of surveys assessing demographics, disease activity, healthcare utilization, health-related quality of life (HRQoL), inflammatory bowel disease–specific self-efficacy, adherence barriers, disease management skills, and substance use in the last 30 days (eg, tobacco use, marijuana use, binge drinking). Exploratory cluster analyses, followed by chi-square tests and analyses of variance examined patterns of substance use and correlates of cluster membership. Results: Four patterns emerged from the sample: Global Users (n = 17), Marijuana Users Engaging in Binge Drinking (n = 18), Exclusive Binge Drinkers (n = 21), and Global Abstainers (n = 76). Groups differed by age, gender, disease activity, healthcare utilization, HRQoL, self-efficacy, and adherence barriers with medium and large effect sizes (P < .05). Conclusions: Older age, male gender, active disease, at least 1 hospitalization in the past year, low self-efficacy, low HRQoL, and high adherence barriers were significantly more likely for those reporting multisubstance use. In addition, all those reporting both marijuana use and binge drinking also reported tobacco use. Future research ought to examine these associations longitudinally and throughout the transition to adult care.

show abstract

Section: What Is Newmentioning

confidence: 99%

Substance Use in Adolescents and Young Adults With Inflammatory Bowel Diseases

Plevinsky

Maddux

Greenley

2019

J. pediatr. gastroenterol. nutr.

Self Cite

View full text Add to dashboard Cite

show abstract

“…Moreover, some existing data suggests that attention to beliefs about medication is an important component of promoting medication adherence in pediatric groups (Carter, 2015). Additionally, our recent work suggests that maladaptive cognitions may be particularly salient for adolescents with IBD (Greenley et al, 2017), offering further support for the value of assessing cognitive barriers to medication taking.…”

Section: Introductionmentioning

confidence: 82%

Reliability and validity of the Beliefs About Medication Scale in pediatric inflammatory bowel disease

Thomason

Poulopoulos

Nguyen

et al. 2017

J Child Health Care

View full text Add to dashboard Cite

Low adherence is a pervasive issue among youth with inflammatory bowel diseases (IBD), yet our understanding of perceived adherence barriers is hampered by a lack of validated instruments. This study sought to address this by evaluating the reliability and predictive validity of the Beliefs About Medication Scale (BAMS) among youth with IBD. Seventy-six youth (ages 11-18) with IBD who were prescribed a daily oral IBD medication completed baseline ratings of perceived adherence barriers via the BAMS. Parents provided information about patient demographic and disease factors. Subjective medication adherence was assessed via the medication adherence measure. Objective medication adherence was assessed via Medication Event Monitoring System (MEMS) Track Caps. BAMS subscales demonstrated adequate internal consistency ( αs = .78-.90) and test-retest reliability ( rs = .64-.79). BAMS subscales reliably distinguished between adherent and low adherent groups, though intent to adhere (IA) was the only independent predictor of adherence status. The BAMS holds promise as a tool for assessing adherence barriers among adolescents with IBD. IA may be of particular value in identifying adolescents at risk for low adherence.

show abstract

A bitter pill to swallow: Medication adherence barriers in adolescents and young adults with inflammatory bowel diseases

Cited by 2 publications

References 35 publications

Substance Use in Adolescents and Young Adults With Inflammatory Bowel Diseases

Substance Use in Adolescents and Young Adults With Inflammatory Bowel Diseases

Reliability and validity of the Beliefs About Medication Scale in pediatric inflammatory bowel disease

Contact Info

Product

Resources

About